Steffen Goletz

Title: Steffen Goletz: Innovator in Genetic Modification

Introduction

Steffen Goletz is a prominent inventor based in Lachen, Switzerland. He has made significant contributions to the field of genetic engineering, particularly through his innovative work involving CRISPR technology. His research focuses on modifying multiple alleles in genes, which has important implications for therapeutic applications.

Latest Patents

Steffen Goletz holds a patent titled "Means and methods for modifying multiple alleles." This invention relates to a method of modifying at least one gene in a cell via CRISPR/Cas, wherein the at least one gene has at least three alleles. The patent also covers cells that can be obtained through this method. Furthermore, it provides a method for producing a protein in a cell that has undergone gene modification, along with the proteins that can be produced and their potential therapeutic uses.

Career Highlights

Steffen Goletz is currently associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. His work at Octapharma AG has allowed him to explore the practical applications of his research in the medical field.

Collaborations

Steffen collaborates with talented professionals such as Karina Nawrath and Janine Guendel. Their combined expertise enhances the research and development efforts at Octapharma AG.

Conclusion

Steffen Goletz is a key figure in the field of genetic modification, with a focus on CRISPR technology and its applications in therapy. His innovative patent and work at Octapharma AG highlight his contributions to advancing medical science.